THE USE OF PHARMACOPHORE MODELING FOR A PURPOSEFUL SEARCH OF POTENTIAL ANTIHYPERTENSIVE AGENTS OF A NUMBER OF DERIVATIVES OF FIVE-MEMBERED HETEROCYCLES

  • I. V. Drapak DANYLO HALYTSKYI LVIV NATIONAL MEDICAL UNIVERSITY
Keywords: pharmacophore modeling, derivatives of five-membered heterocycles – 1,3-thiazole, 1,3,4-thiadiazole, 1,3,4-triazole, antihypertensive activity

Abstract

Introduction. Pharmacophore modeling is one of the most effective virtual screening methods. This method allows to determine the set and relative arrangement of specific molecular fragments that are required for the manifestation of a particular biological activity. Increased blood pressure is a major cause of cardiac, vascular, and cerebral complications, including ischemic heart disease, chronic heart failure, and circulatory disorders. Purposeful search for antihypertensive agents using the latest methods, including pharmacophore modeling, among derivatives of five-membered heterocycles is appropriate and relevant. Pharmacophore modeling is one of the most effective virtual screening methods. This method allows to determine the set and relative arrangement of specific molecular fragments that are required for the manifestation of a particular biological activity. Increased blood pressure is a major cause of cardiac, vascular, and cerebral complications, including ischemic heart disease, chronic heart failure, and circulatory disorders. Purposeful search for antihypertensive agents using the latest methods, including pharmacophore modeling, among derivatives of five-membered heterocycles is appropriate and relevant.

The aim of the study – the pharmacophore modeling of a series of five-membered heterocycle derivatives, 1,3-thiazole, 1,3,4-thiadiazole, and 1,3,4-triazole, for the purposeful search for potential antihypertensive agents.

Research Methods. 1,3-thiazole, 1,3,4-thiadiazole and 1,3,4-triazole derivatives with established antihypertensive activity were synthesized as objects of study. Pharmacophore modeling was performed in a specialized program for molecular modeling of chemoinformatics Molecular Operating Environment.

Results and Discussion. In the process of searching for a probable pharmacophore, pharmacophore models have been developed that are characterized by different composition and coordinates of pharmacophore centers, as well as classification accuracy. For the detection and screening of antihypertensive effects, four-component pharmacophore models were selected with a classification accuracy of 0.52–0.61 and an overlap of active compounds of 1.76–2.78. Pharmacophore model with the highest accuracy and degree of overlap structurally consists of an aromatic ring, two hydrophobic regions and a projection of a hydrogen bond acceptor with a characteristic mutual spatial arrangement and through the aromatic interaction mechanism. The structures of the virtual base molecule structures were harmonized with the pharmacophore model.

Conclusions. Conducted pharmacophore modeling of a number of derivatives of five-membered heterocycles – 1,3-thiazole, 1,3,4-thiadiazole and 1,3,4-triazole with established antihypertensive activity made it possible to distinguish a possible pharmacophore consisting of an aromatic ring, two Hydrophobic Areas and Projections of the Hydrogen Bond Acceptor. The accuracy of the classification of active and inactive compounds in this model is 0.61. The resulting pharmacophore model can be used for virtual screening and targeted search for new antihypertensive agents.

 

Key words: pharmacophore modeling, derivatives of five-membered heterocycles – 1,3-thiazole, 1,3,4-thiadiazole, 1,3,4-triazole, antihypertensive activity.

References

Katsila, T., Spyroulias, G.A., Patrinos, G.P., & Matsoukas, M.T. Computational approaches in target identification and drug discovery (2016). Minos-Timotheos Matsoukas a Computational and Structural Biotechnology Journal, 14, 177-184. doi: 10.1016/j.csbj.2016.04.004.

Yang S.Y. (2010). Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discovery Today, 15 (11-12), 444-450. https://doi.org/10.1016/j.drudis.2010.03.013

Drozdz, D., & Kawecka-Jaszcz, K. (2014). Cardio­vascular changes during chronic hypertensive states. Pediatr. Nephrol., 29 (9), 1507-1516. doi: 10.1007/s00467-013-2614-5.

Ezzati, M., Lopez, A.D., Rodgers, A., Vander Hoorn, S., & Murray, C.J. (2002). Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet, 360 (9343), 1347-1360. doi: 10.1016/S0140-6736(02)11403-6.

Ross, S.D., Akhras, K.S., Zhahg, S., & Rozinsky, M. (2001). Discontinuation of antihypertensive drugs due to adverse events. a systematic review and meta-analysis. Pharmacotherapy, 21 (8), 940-953. doi: 10.1592/phco.21.11.940.34520

Drapak, I.V. (2019). In silico scryninh likopodidnyh molekul dlia likuvannia sertsevo-sudynnykh zakhvoriuvan na osnovi pryvileiovanykh piatychlennykh heterotsytiv [In silico screening of drug-like molecules for the treatment of cardiovascular diseases on the basis of five-membered privileged heterocycles]. Farmatsevtychnyi zhurnal – Pharmaceutical Journal, 4, 61-72 [in Ukrainian].

Perekhoda, L., Yeromina, H., Drapak, I., Kobzar, N., Smolskiy, O., & Demchenko, N. (2017). The antioxidant properties of 1-[2-(R-phenylimino)-4-methyl-3-(3-[morp­holine-4yl]propyl)-2,3-dihydro-1,3-thiazol-5-yl]ethane-1-one derivatives under conditions of artificial oxidative stress in vitro. Saudi Journal of Medical and Pharmaceutical Sciences, 3 (1), 55-59.

Drapak, I., Perekhoda, L., Demchenko, N., Suleiman, M., Rakhimova, M., Demchuk, I., …, & Gerashchen­ko, I. (2019). Cardioprotective Activity of Some 2-Ary­limino-1, 3-Thiazole Derivatives. Scientia Pharmaceutica, 87, 7, 8. doi:10.3390/scipharm87010007

Drapak, І.V. (2019). Syntes, doslidzhennia diuretychnoi aktyvnosti ta QSAR-analiz N-(1,3,4-thiadiazol-2-yl)zamishchenyh amidiv kyslot alkankarbonovoho riadu [Synthesis, diuretic activity research and QSAR-analysis of N-(1,3,4-tiadiazol-2-il)substituted amides of alkanecarboxylic acids]. Farmatsevtychnyi zhurnal – Pharmaceutical Journal, 2, 55-65 [in Ukrainian].

Drapak, I.V., Zimenkovskyi, B.S., Seredinska, N.M., & Demchenko, A.M. (2019). Patent na korysnu model № 135563 u201900319 hidrohloryd 1-{3-[2-(3,4-dymetoxy-phenil)-etyl]-4-metyl-1-2-phenilimino-2,3-dyhidro-thiazol-5-yl}-etanonu, shcho proiavliaie hipotenzyvnu diiu [Utility model patent u201900319 1-{3-[2-(3,4-Dimethoxy-phenyl)-ethyl]-4-methyl-1-2-phenylimino-2,3-dihydro-thiazol-5-yl}-ethanone hydrochloride, which is hypotensive action]. Applicant and patentee of Danylo Halytskyi Lviv National Medical University. Claimed 01/11/19; publ. 07/10/19. Bul. No. 13. [in Ukrainian].

Sych, I.V., Drapak, I.V., Suleiman, M.M., Rakhi­mova, M.V., Kobzar, N.P., Sych, I.A., & Perekhoda, L.O. (2019). Search for biologically active substances with antimicrobial and antifungal action in the series of 2.5-disubstituted 1, 3, 4-tiadiazoles. Research Journal of Pharmacy and Technology, 12 (6), 1-6.

Perekhoda, L.O., Коbzar, N.P., & Drapak, І.V. (2016). The synthesis and physicochemical properties of new derivatives of 5-R-phenylamino-2-mercapto-1,3,4-tiadiazole. News of Pharmacy, 1 (85), 24-28.

Yeromina, H.O., Drapak, I.V., Ieromina, Z.H., Perekhoda, L.O., & Heorhiiants, V.A. (2019). Aminome­thylation of 1,2,4-triazole-3-thiones containing piperidine moiety in order to synthesine new biologically active compounds. Proceedings of the scientific-practical conference with international participation, dedicated to the 20th anniversary of the founding of the Day of the Phar­maceutical Worker of Ukraine: Suchasna farmatsiia: istoriia, realii ta perspektyvy rozvytku (19-20 ver 2019) – Modern Pharmacy: History, Realities and Prospects of Development (19-20 Sept 2019). Kharkiv [in Ukrainian].

Stefanova, O.V. (Ed.). (2001). Doklinichni doslidzhennia likarskykh zasobiv (metodychni rekomendatsii) [Preclinical drug research: a method. recom.]. Кyiv: Avitsena [in Ukrainian].

Chemical Computing Group Inc. MOE 2007.09 (Molecular OperatingEnvironment software). Retrieved from: http://www.chemcomp.com.

Kellici, T.F., Ntountaniotis, D., Kritsi, E., Zervou, M., Zoumpoulakis, P., Potamitis, C., …, & Mavro­moustakos, T. (2016). Leveraging NMR and X-ray data of the free ligands to build better drugs targeting angio­tensin II type 1 G-protein coupled receptor. Current Me­dicinal Chemistry, 23, 1, 36-59.

Published
2019-11-09
How to Cite
Drapak, I. V. (2019). THE USE OF PHARMACOPHORE MODELING FOR A PURPOSEFUL SEARCH OF POTENTIAL ANTIHYPERTENSIVE AGENTS OF A NUMBER OF DERIVATIVES OF FIVE-MEMBERED HETEROCYCLES. Medical and Clinical Chemistry, (3), 104-110. https://doi.org/10.11603/mcch.2410-681X.2019.v.i3.10567
Section
ORIGINAL INVESTIGATIONS